Clinical Trial Update: Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating diagnostic efficacy, pharmacokinetics, and safety of 68Ga-DOTATATE PET/CT for detecting neuroendocrine tumors; currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Drugs mentioned

• 68Ga-DOTATATE (Gallium-68 DOTATATE)

Snippet

Sponsor: HTA Co., Ltd. | Conditions: NETs | Phase 3 | Status: ACTIVE_NOT_RECRUITING